Post-approval studies (Phase 4)Ended earlyNCT00140894
What this trial is testing
Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Who this might be right for
Adenomatous Polyposis Coli
Merck Sharp & Dohme LLC 62
Showing 20 of 167 results